Forest Laboratories, Inc.

Forest Laboratories, Inc.

  • 909 3rd Ave
  • New York, New York
  • 10022
  • Phone: (212) 421-7850
  • Fax: (201) 524-9711
  • Website

Description

Forest has well-established franchises in therapeutic areas of the central nervous, cardiovascular and respiratory systems, and we are always exploring new product opportunities that address a range of health conditions. Our principal brands include LexaproForest identifies, develops and delivers pharmaceutical products that make a difference in people's lives. Lexapro is one of the fastest-growing SSRI antidepressant in the United States. Benicar has become an important treatment option for hypertension. Namenda is the first approved therapy in the United States for those with moderate or severe Alzheimer's disease."We have been extremely successful in meeting our business objectives and expanding our franchises," says Howard Solomon, Forest's chairman and chief executive officer. "But there is a satisfaction beyond profits in helping to bring relief to people who are suffering."

Fact sheet

Number of employees
5276
Annual revenue
$3908340992

Products & services

Similar companies nearby